The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,264.00
Bid: 12,280.00
Ask: 12,282.00
Change: 146.00 (1.20%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Credit Suisse likes Hargreaves Lansdown, abrdn

Tue, 25th Jan 2022 09:57

(Alliance News) - The following London-listed shares received analyst recommendations tuesday morning:

----------

FTSE 100

----------

UBS RAISES NATWEST TO 'BUY' (NEUTRAL) - PRICE TARGET 290 (230) PENCE

----------

UBS RAISES STANDARD CHARTERED PRICE TARGET TO 580 (530) PENCE - 'BUY'

----------

UBS RAISES LLOYDS PRICE TARGET TO 62 (60) PENCE - 'BUY'

----------

UBS RAISES HSBC PRICE TARGET TO 590 (500) PENCE - 'BUY'

----------

UBS RAISES BARCLAYS PRICE TARGET TO 265 (250) PENCE - 'BUY'

----------

CREDIT SUISSE STARTS ABRDN WITH 'OUTPERFORM' - PRICE TARGET 290 PENCE

----------

CREDIT SUISSE STARTS HARGREAVES LANDSDOWN WITH 'OUTPERFORM' - PRICE TARGET 1,590 PENCE

----------

CREDIT SUISSE STARTS SCHRODERS WITH 'NEUTRAL' - PRICE TARGET 3,700 PENCE

----------

CITIGROUP RAISES BAE SYSTEMS PRICE TARGET TO 736 (670) PENCE - 'BUY'

----------

LIBERUM RAISES ASTRAZENECA PRICE TARGET TO 9,610 (9,220) PENCE - 'BUY'

----------

RBC CUTS NATIONAL GRID TO 'SECTOR PERFORM' (OUTPERFORM) - PRICE TARGET 1,100 (1,040) PENCE

----------

RBC RAISES RIGHTMOVE PRICE TARGET TO 600 (560) PENCE - 'UNDERPERFORM'

----------

RBC RAISES AUTO TRADER GROUP PRICE TARGET TO 750 (670) PENCE - 'SECTOR PERFORM'

----------

RBC CUTS OCADO PRICE TARGET TO 1,700 (2,100) PENCE - 'SECTOR PERFORM'

----------

RBC RAISES SSE PRICE TARGET TO 1,825 (1,800) PENCE - 'SECTOR PERFORM'

----------

BERENBERG CUTS INTERNATIONAL CONSOLIDATED AIRLINES PRICE TARGET TO 180 (200) PENCE - 'HOLD'

----------

ODDO BHF CUTS WPP TO 'NEUTRAL' (OUTPERFORM)

----------

BARCLAYS RAISES ST JAMES'S PLACE TARGET TO 1,765 (1,699) PENCE - 'EQUAL WEIGHT'

----------

FTSE 250

----------

UBS RAISES VIRGIN MONEY PRICE TARGET TO 230 (220) PENCE - 'BUY'

----------

MORGAN STANLEY CUTS HOMESERVE PRICE TARGET TO 810 (1,020) PENCE - 'EQUAL-WEIGHT'

----------

JEFFERIES RAISES DOMINO'S PIZZA TARGET TO 360 (260) PENCE - 'UNDERPERFORM'

----------

DEUTSCHE BANK CUTS TRAINLINE PRICE TARGET TO 266 (351) PENCE - 'HOLD'

----------

RBC RAISES CENTRICA PRICE TARGET TO 90 (75) PENCE - 'OUTPERFORM'

----------

RBC RAISES SERCO GROUP PRICE TARGET TO 190 (170) PENCE - 'OUTPERFORM'

----------

RBC CUTS MONEYSUPERMARKET.COM TARGET TO 260 (280) PENCE - 'SECTOR PERFORM'

----------

RBC RAISES DRAX GROUP PRICE TARGET TO 925 (750) PENCE - 'OUTPERFORM'

----------

CREDIT SUISSE RAISES MAN GROUP PRICE TARGET TO 250 (240) PENCE - 'OUTPERFORM'

----------

JEFFERIES CUTS IBSTOCK PRICE TARGET TO 217 (225) PENCE - 'HOLD'

----------

SMALL CAP

----------

UBS RAISES SOUTH32 PRICE TARGET TO 240 (230) PENCE - 'BUY'

----------

RBC CUTS JUST EAT TAKEAWAY PRICE TARGET TO 60 (66) EUR - 'SECTOR PERFORM'

----------

RBC RAISES THG TO 'OUTPERFORM' (SECTOR PERFORM) - PRICE TARGET 500 PENCE

----------

RBC CUTS BOOHOO TO 'SECTOR PERFORM' (OUTPERFORM) - PRICE TARGET 150 (330) PENCE

----------

JPMORGAN CUTS ITM POWER PRICE TARGET TO 410 (500) PENCE - 'NEUTRAL'

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.